Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 742
  • Print this page
  • Email this page

    Article Cited by others


Leishmaniasis in the Argentine Republic: Temporal and geographical distribution from 2013 to 2017

Germano María J, Salomón María C, Neira Gisela, Lozano Esteban, Mackern-Oberti Juan P, Cargnelutti Diego E

Year : 2019| Volume: 12| Issue : 7 | Page no: 300-305

   This article has been cited by
1 Antiparasitic potential of asteraceae plants: A comprehensive review on therapeutic and mechanistic aspects for biocompatible drug discovery
Chinnaperumal Kamaraj, Chinnasamy Ragavendran, Rajappan Chandra Satish Kumar, Amir Ali, Safir Ullah Khan, Zia ur-Rehman Mashwani, Juan Pedro Luna-Arias, Juan Pedro Ramirez Pedroza
Phytomedicine Plus. 2022; 2(4): 100377
[Pubmed]  [Google Scholar] [DOI]
2 Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis
María José Germanó, Juan Pablo Mackern-Oberti, Jessica Gardone Vitório, Mariana Costa Duarte, Daniel Carvalho Pimenta, Maria Victoria Sanchez, Flavia Alejandra Bruna, Esteban Sebastián Lozano, Ana Paula Fernandes, Diego Esteban Cargnelutti
Frontiers in Immunology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
3 Estudio clínico y epidemiológico de Leishmaniasis Cutánea en un Hospital Nivel II Del Perú
Charles Frank Saldaña-Chafloque, Miguel Ivan Saldaña-Alfaro, Rosita Isabel Saldaña-Chafloque, Mercedes Acosta-Román
Llamkasun. 2021; 2(4): 23
[Pubmed]  [Google Scholar] [DOI]
4 Therapeutic effect of Prosopis strombulifera (LAM) BENTH aqueous extract on a murine model of cutaneous leishmaniasis
Esteban Sebastián Lozano,María José Germanó,Mariana Elizabeth Troncoso,María Fernanda García Bustos,Carlos Gamarra Luques,Diego Esteban Cargnelutti
Journal of Traditional and Complementary Medicine. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Evaluation of different total Leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a Toll-like receptor-3 agonist to prevent cutaneous leishmaniasis
María José Germanó,Esteban Sebastián Lozano,María Victoria Sanchez,Flavia Alejandra Bruna,María Fernanda García-Bustos,Arianna Lourdes Sosa Lochedino,María Cristina Salomón,Ana Paula Fernandes,Juan Pablo Mackern-Oberti,Diego Esteban Cargnelutti
Memórias do Instituto Oswaldo Cruz. 2020; 115
[Pubmed]  [Google Scholar] [DOI]


Read this article